| 1.399 -0.101 (-6.73%) | 10-08 13:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.86  |
1-year : | 2.18 |
| Resists | First : | 1.6 |
Second : | 1.86 |
| Pivot price | 0.96 |
|||
| Supports | First : | 1 |
Second : | 0.63 |
| MAs | MA(5) : | 1.26 |
MA(20) : | 0.9 |
| MA(100) : | 1.29  |
MA(250) : | 4.86 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 83.6 |
D(3) : | 86.9 |
| RSI | RSI(14): 70.6 |
|||
| 52-week | High : | 17.17 | Low : | 0.63 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AEON ] has closed below upper band by 8.2%. Bollinger Bands are 6.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.57 - 1.58 | 1.58 - 1.58 |
| Low: | 1.23 - 1.23 | 1.23 - 1.24 |
| Close: | 1.49 - 1.5 | 1.5 - 1.51 |
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Mon, 07 Oct 2024
AEON Biopharma Releases New Investor Presentation - TipRanks
Tue, 01 Oct 2024
AEON Biopharma stock earns buy rating, holds price target on FDA meeting - Investing.com
Mon, 30 Sep 2024
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - The Manila Times
Mon, 30 Sep 2024
AEON Biopharma, Inc. Announces Positive Outcome from FDA Biosimilar Advisory Meeting - Marketscreener.com
Mon, 30 Sep 2024
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - StockTitan
Wed, 21 Aug 2024
AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 40 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 36.6 (%) |
| Held by Institutions | 23.8 (%) |
| Shares Short | 127 (K) |
| Shares Short P.Month | 623 (K) |
| EPS | -0.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.71 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -597.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.11 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -43 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -9.33 |
| PEG Ratio | 0 |
| Price to Book value | -1.97 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|